Hefei Xingmou Biotechnology Co., Ltd.
PrivateLast Round
Series A
Extension
Sep 12, 2025
Company Overview
Hefei Xingmou Biotechnology Co., Ltd. operates in Healthcare & Life Sciences and is based in Hefei. Its latest recorded funding round was a Series A Extension round in September 2025.
Hefei Xingmou Biotechnology Co., Ltd. is a biotechnology company that develops gene therapy drugs for ophthalmic diseases and researches gene editing technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hefei Xingmou Biotechnology Co., Ltd. Comparables
Compare Hefei Xingmou Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sansure Biotech Inc. | 73% | |
| Daan Gene Co., Ltd. | 72% | |
| Berry Genomics Co., Ltd. | 67% |
For institutional investors. Book with your work email.
Hefei Xingmou Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 12, 2025 | ||||
| Series A | Mar 18, 2024 | ||||
| Pre Seed | Mar 24, 2022 | ||||
| Angel | Nov 1, 2020 |
For institutional investors. Book with your work email.
Hefei Xingmou Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Co-Win Ventures | Series A |
| Hefei Innovation Technology Venture Capital | Series A |
| China Science and Technology Industry Investment Management | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2025
Completed a Series A Extension round.
- Mar 18, 2024
Co-Win Ventures led the Series A round.
For institutional investors. Book with your work email.
Hefei Xingmou Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hefei Xingmou Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Hefei Xingmou Biotechnology Co., Ltd. a public or private company?
Hefei Xingmou Biotechnology Co., Ltd. is a private company.
What is the current stock price of Hefei Xingmou Biotechnology Co., Ltd.?
Hefei Xingmou Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Hefei Xingmou Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hefei Xingmou Biotechnology Co., Ltd. worth (valuation)?
Valuation information for Hefei Xingmou Biotechnology Co., Ltd. is not publicly available.
Can I buy Hefei Xingmou Biotechnology Co., Ltd. stock?
Hefei Xingmou Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hefei Xingmou Biotechnology Co., Ltd.'s last funding round?
Hefei Xingmou Biotechnology Co., Ltd.'s most recent funding round was Series A Extension on September 12, 2025.
Who are the main investors in Hefei Xingmou Biotechnology Co., Ltd.?
Key investors in Hefei Xingmou Biotechnology Co., Ltd. include Co-Win Ventures, China Science and Technology Industry Investment Management.
Will Hefei Xingmou Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Hefei Xingmou Biotechnology Co., Ltd..
How can I track Hefei Xingmou Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Hefei Xingmou Biotechnology Co., Ltd.'s shares on secondary markets.